| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut National de la Santé et de la Recherche Médicale, Unité 407, Oullins F-69921; Faculté de Médecine Lyon-Sud (A.F., M.M., A.B., A.H., S.C., M.B.), Lyon F-69921, France; BayerCorpScience (R.B.), Sophia-Antipolis F-06903; and Galderma (F.C.), Sophia-Antipolis F-06560, France
Address all correspondence and requests for reprints to: Dr. Mohamed Benahmed, Institut National de la Santé et de la Recherche Médicale, Unité 407, Faculté de Médecine Lyon-Sud, BP 12, 69921 Oullins Cedex, France. E-mail: benahmed{at}grisn.univ-lyon1.fr.
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Claudin-11, also known as oligodendrocyte-specific protein (OSP), belongs to the claudin family of intrinsic transmembrane proteins (16). First described in the myelin sheaths of the central nervous system (17), studies have shown that it is specifically expressed in oligodendrocytes in the brain and Sertoli cells in the testis, where it is responsible for the formation of specific parallel tight junction strands (16, 18, 19). In the mouse testis, claudin-11 has been shown to be hormonally regulated (FSH and testosterone) (20, 21) and is a key factor in establishment of the hemotesticular barrier. Indeed, testicular claudin-11 expression is at its maximum between postnatal d 6 and 16, during the formation of the hemotesticular barrier (20), and mice invalidated for this gene are infertile, with the loss of claudin-11 expression causing a disruption of this barrier, leading to an arrest in spermatogenesis (19).
In the present study we investigated whether fetal exposure to flutamide affected claudin-11 messenger and protein levels in rat Sertoli cells at the time of two key events in postnatal testis development: 1) before puberty (postnatal d 14) during the establishment of the hemotesticular barrier, and 2) in adulthood (postnatal d 90) at the time of full spermatogenesis when all germ cell types are present. Claudin-11 mRNA and protein levels were also studied in the brain of adult male rats exposed in utero to the antiandrogen.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-33P]dATP. Oligonucleotides were purchased from Invitrogen Life Technologies, Inc. (Groningen, The Netherlands).
Animals
Virgin female Sprague Dawley rats (Charles River Laboratories, Saint Aubin les Elbeuf, France) were individually housed under controlled conditions of lighting (12 h of light, 12 h of darkness), temperature (22 ± 2 C), humidity (55 ± 15%), and ventilation (
15 air changes/h) and were given free access to water and feed (certified rodent pellet diet A04C, UAR, Villemoisson-sur-Orge, France). Females were mated on a one to one basis with males of the same strain, purchased from the same supplier. Day 0 of gestation (GD0) was the day a vaginal sperm plug was observed. Before mating and during gestation, dams were housed in suspended stainless steel wire mesh cages. Shortly before parturition and during lactation, dams were housed in Makrolon cages (Charles River) with soft wood bedding.
Pregnant rats were administered daily the vehicle (methylcellulose) alone or flutamide by gavage from GD10 to the day before delivery (GD21 or GD22). Animals were administered flutamide at doses of 0, 0.4, 2, and 10 mg/kg body weight·d (adjusted daily for body weight). Dams were weighed daily from GD10 to the day of delivery. At birth, each pup was sexed, weighed, and identified. The male offspring received no flutamide treatment and were raised until study termination (postnatal d 14 or 90), when rats were euthanized by CO2 asphyxiation. The position of each testis was carefully noted. Moreover, each testis was weighed before being fixed or frozen. Only bilateral descended testes were studied in the present report. All studies using animals were conducted in accordance with current regulation and standards approved by Institut National de la Santé et de la Recherche Médicale (French Institute for Health and Medical Research) animal care committee.
Irradiation
Adult Sprague Dawley (90 d old) rats purchased from Iffa-Credo (L’Arbresle, France) were housed in controlled conditions of lighting (12 h of light, 12 h of darkness), temperature (22 ± 2 C), humidity (55 ± 15%), and ventilation (15 air changes/h) and were given free access to water and feed (certified rodent pellet diet, AO4C, UAR). Before the experimental procedure, an acclimation period of 1 wk was allowed. All rats were anesthetized by ip injection of sodium phenobarbital (45 mg/kg; Sanofi Santé Animale, Libourne, France) 20 min before irradiation. The scrotum of each rat was irradiated by x-ray at a dose of 9 Gy. A 120-kv x-ray beam with 2-mm Al filtration was generated by a Stabilipan (Siemens AG, Erlangen, Germany) orthovoltage machine. A 4-cm diameter lead collimator was used to selectively irradiate both testes while protecting the other organs at risk in the rats. The distance between source and skin was 40 cm. The dose was prescribed and specified at 2.5 mm under the skin of the scrotum, at the center of the testes. Control animals received anesthesia and sham irradiation. Irradiated and sham-irradiated animals were euthanized by CO2 inhalation 10, 26, or 45 d after the experiments. One group of control animals was killed 10 d after sham irradiation, and the other group was killed 45 d after sham irradiation. Each control and treatment group consisted of six animals. For each rat, the left testis was removed and fixed for 24 h in Bouin’s fixative, and the right testis was removed for RNA and protein extractions.
Isolation and culture of Sertoli cells
Primary Sertoli cells were isolated from 20-d-old Sprague Dawley rats, as described by Dorrington et al. (22). Briefly, decapsulated testes were submitted to collagenase dissociation (0.5 mg/ml, 5 min at 30 C) in DMEM/F12 (1:1, vol/vol) medium (1.2 mg/ml sodium bicarbonate, 15 mM HEPES, and 20 µg/ml gentamicin) containing deoxyribonuclease I (0.05 mg/ml). At the end of enzymatic dissociation, testicular cells were washed three times by submitting them to gravity sedimentation (3–5 min), and supernatants were removed. The pellets containing the sedimented tubules were also dissociated with a collagenase-dispase treatment, as described above, until small clumps resulted. Cells were then submitted to gravity sedimentation (10–15 min), supernatants were removed, and the sedimented clumps of Sertoli cells were also washed by centrifugation (200 x g, 10 min). Sertoli cell pellets were resuspended in DMEM/F12 medium (supplemented with 5 µg/ml transferrin, 2 µg/ml insulin, and 10 µg/ml vitamin E), and cells were plated on Falcon petri dishes (BD Biosciences, Franklin Lakes, NJ; 100-mm diameter, 7 x 106 cells/dish) and cultured at 32 C in a humidified atmosphere of 5% CO2-95% air. This procedure led to a Sertoli cell population free from Leydig cells or mature germ cells, but which contained approximately 15–20% peritubular myoid cells (data not shown). For the coculture studies, 2 x 106 Sertoli cells were seeded in 6-cm diameter petri dishes. Testicular germ cells (spermatocytes and spermatids) were isolated from adult rats (90 d old) as described by Boussouar et al. (23). Three groups of cultured cells were generated: Sertoli cells cultured alone without germ cells, Sertoli cells cultured with spermatocytes (2 x 106 cells), and Sertoli cells cultured with spermatids (2 x 106 cells). The cells were collected after 72 h of culture. Experiments were repeated at least three times with independent cell preparations.
Total RNA extraction
Total RNAs were extracted using TRIzol, a monophasic solution of phenol and guanidine isothiocyanate, following an improvement of the single-step RNA isolation method developed by Chomczynski and Sacchi (24). The final amount of RNA was estimated by spectrophotometry at 260 nm.
Coamplification RT-PCR with an endogenous control
Coamplification RT-PCR (25) was performed to determine the mRNA levels of claudin-11, AR, and FSH receptor (FSH-R). Briefly, approximately 2 µg total RNA were reverse-transcribed into cDNAs (cDNAs) for 1 h at 37 C using Moloney murine leukemia virus reverse transcriptase (10 U/µl) in 1x first strand buffer, random hexanucleotides as primers (5 µM), dNTPs (250 µM), and dithiothreitol (10 µM). PCRs were then performed on 2 µl RT product, using the appropriate sense- and antisense-specific primers, Taq polymerase (0.5 U), 1x PCR buffer, 2.5 mM MgCl2, dNTPs, and 0.75 µCi [-33P]dATP. Claudin-11 (0.055 or 1 µM) was coamplified with GATA-6 (1 µM) or with the ß-actin (0.1 µM) primer pair, GATA-6 (1 µM) was coamplified with ß-actin (0.04 µM), FSH-R (1 µM) was coamplified with GATA-6 (1 µM), and AR (0.5 µM) was coamplified with hypoxanthine phosphoribosyltransferase (HPRT; 0.5 µM). Coamplification with ß-actin or HPRT was performed to check that equal amounts of cDNAs were amplified in each reaction tube, and coamplification with the GATA-6 gene was performed to compare claudin-11 and FSH-R mRNA levels with those of another Sertoli cell-specific gene, so as to detect eventual changes in the proportion of this cell type in the testes from flutamide-treated or irradiated animals. PCR mixes were submitted to an initial denaturing step at 95 C, followed by X cycles consisting of 30-sec denaturation at 95 C, 30-sec annealing at melting temperature (Tm), and 30-sec extension at 72 C, and the reaction ended with a final extension step at 72 C: claudin-11: X, 19 cycles; Tm, 55 C; GATA-6: X, 19 cycles; Tm, 55 C; AR: X, 25 cycles; Tm, 55 C; and FSH-R: X, 24 cycles; Tm, 65 C. Primers were as follows: for claudin-11: upstream primer, 5'-GATTGGCATCATCGTCACAACG-3'; downstream primer, 5'-AGCCAGCAGAATAAGGAGCAAC-3' (339 bp); for GATA-6: upstream primer, 5'-GTGCCAACCCTGAGAACAGT-3'; downstream primer, 5'-TGGACTGCTGGACAAAATCA-3' (198 bp); for ß-actin: upstream primer, 5'-TTGCTGATCCACATCTGCTG-3'; downstream primer, 5'-GACAGGATGCAGAAGGAGAT-3' (146 bp); for AR: upstream primer, 5'-ATTGTCCATCGTGTCGTCTCC G-3'; downstream primer, 5'-GAGTTGACATTAGTGAAGGACC-3' (447 bp); for HPRT: upstream primer, 5'-CCTGCTGGATTACATTAA AGC-3'; downstream primer, 5'-GTCAAGGGCATATCCAACAAC-3' (354 bp); and for FSH-R: upstream primer, 5'-CTCATCAAGCGACACCAAGA-3'; downstream primer, 5'-ACCTTGAGGGAGGCAGAAAT-3' (108 bp). PCR products were resolved on 8% polyacrylamide gels, which were exposed to a Storage Phosphor Screen (Packard, Meriden, CT), and the signals were analyzed using Cyclone OptiQuant software (Packard). Results from at least three separate experiments were used for statistical analysis.
PCR analyses were carried out from the logarithmic phase of amplification, and different cycle numbers were tested for each primer pair to determine the minimum number of cycles necessary to detect the PCR product. Primers were designed inside separate exons to avoid any bias caused by residual genomic contamination. For all primers, no amplification was observed when PCR was performed on RNA preparations. Finally, PCR-amplified products were checked by direct sequencing using an automated sequencer (ABI PRISM 310, Applied Biosystems, Foster City, CA).
Western blotting analysis
Proteins (40 µg) from whole adult testis or brain were separated on 10% (AR) or 12% (claudin-11) sodium dodecyl sulfate-polyacrylamide gels and electrophoretically transferred to nitrocellulose membranes using 25 mM Tris and 185 mM glycine for claudin-11 or 15 mM Tris and 120 mM glycine for AR, pH 8.3, containing 20% methanol. Transfer was performed at a constant voltage of 100 V for 1 h. After transfer, membranes were blocked in Tris-buffered saline containing 0.05% Tween (TBS-T) containing 3% BSA (claudin-11) or 5% milk (AR), and incubated with the primary antibody [1:2000 for anticlaudin-11 (Covalab, Lyon, France) or 1:200 for anti-AR (sc-816, Santa Cruz Biotechnology, Inc., Santa Cruz, CA)] in TBS-T overnight at 4 C. Membranes were then incubated with horseradish peroxidase-labeled goat antirabbit (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA; 1:2000 in TBS-T) for 1 h at room temperature, and bound antibodies were subsequently detected using a chemiluminescence detection kit (Covalab) and Biomax MR films (Eastman Kodak Co., Rochester, NY). Protein concentrations were determined by the Bradford assay. Reprobing the blot with a rab-bit immunoglobulin G antiactin (20-33, Sigma-Aldrich Corp., L’Isle d’Abeau, France; concentration, 1:500 in TBS-T) checked protein loading.
Terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL)
Testes were immediately fixed for 24 h in Bouin’s fluid, stepwise dehydrated in graded ethanol baths, and embedded in paraffin. Paraffin sections of Bouin-fixed testes were sectioned at 5 µm. The sections were mounted on positively charged glass slides (SuperFrost Plus, Menzel-Glaser, Braunschweig, Germany), deparaffinized, hydrated, treated for 20 min at 93–98 C in citric buffer (0.01 M, pH 6), rinsed in osmosed water (twice, 5 min each time), and washed (twice, 5 min each time) in TBS, pH 7.8. TUNEL reaction was performed as previously described (26), and slides were counterstained for 2 min with Mayer’s hematoxylin. In each rat testis, at least 100 random seminiferous tubules were counted. The results are expressed as the number of TUNEL-positive cells per 100 seminiferous tubules.
Hormone assay
Blood samples, taken from 14- or 90-d-old rats selected in each control or treated group across litters, were taken by retroorbital puncture after isoflurane anesthesia. Plasma samples were kept frozen until testosterone or FSH was analyzed using a specific RIA. Specific kits were supplied by Amersham Biosciences (Orsay, France) for FSH and by Im-munotech (Marseille, France) for testosterone. Packard provided the RIASTAR program (Canberra Co., Meriden, CT).
Data analysis
Data are expressed as the mean ± SEM. At least four different male offspring (n = 4–11/condition) from different litters were used. For statistical analysis, one-way ANOVA was performed to determine differences among all groups (P < 0.05), and the Bonferroni/Dunn posttest was performed to determine the significance of the differences between pairs of groups. P < 0.05 was considered significant. The statistical tests were performed on StatView software (version 5.0, SAS Institute, Inc., Cary, NC) on a Macintosh computer (Apple Computer, Cupertino, CA).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
show that claudin-11 mRNA levels were significantly reduced in testes from 14-d-old rats treated in utero with 2 (35% decrease; P < 0.0001) and 10 (50% decrease; P = 0.0001) mg/kg·d flutamide. In parallel, a decrease in claudin-11 protein was observed in a significant (30% decrease; P = 0.008) manner at 10 mg/kg·d flutamide (Fig. 1B).
|
shows that in the adult (90 d old) testes treated in utero with 2 mg/kg·d flutamide, claudin-11 mRNA levels were significantly reduced by 25% (P < 0.0001), whereas at the dose of 10 mg/kg·d flutamide, such a decrease in claudin-11 mRNA levels was no longer observed in adult testes compared with prepubertal (14 d old) testes.
Data obtained by Western blotting analysis showed similar results for protein levels (Fig. 1D). Indeed, in adult rat testes exposed in utero to 2 mg/kg·d flutamide, a 50% decrease in claudin-11 protein levels was found (P < 0.005), and again, in the 10 mg/kg·d-treated rats, this decrease in testicular claudin-11 levels was not observed.
To determine the specificity of claudin-11 expression changes in Sertoli cells, we evaluated in parallel AR mRNA and protein levels, FSH-R mRNA levels, and the expression of the gene coding for GATA-6, a transcription factor member of the GATA-binding protein family that is specifically expressed in Sertoli cells (27). AR mRNA (data not shown) and protein levels in prepubertal (Fig. 2A) and adult (Fig. 2B) rat testes were not affected after in utero exposure to the various doses of flutamide. Similarly, FSH-R mRNA levels in prepubertal (Fig. 2C) and adult (Fig. 2D) rat testes were not modified by fetal treatment with the antiandrogen, as were GATA-6 mRNA levels in prepubertal (data not shown) or adult (Fig. 2E) rat testes.
|
show that plasma testosterone levels were not significantly affected in either prepubertal (14 d old) or adult (90 d old) rats exposed in utero to flutamide. Similarly, FSH levels in adult rats exposed in utero to flutamide were not altered (Table 2). Taken together, the data in Fig. 2 and Tables 1 and 2 indicate that the alterations in claudin-11 expression in prepubertal and adult testes exposed in utero to flutamide were not related to altered androgen and/or FSH plasma levels and/or changes in AR/FSH-R expression.
|
|
Claudin-11 expression is under positive control of testosterone in testis
To study the regulation by androgens of claudin-11 expression, messenger and protein levels were evaluated in a model of cultured rat Sertoli cells. Sertoli cells were treated with various concentrations of testosterone (7 nM to 3.5 µM; 2–1000 ng/ml) for various periods (4–96 h). The data in Fig. 3A show that claudin-11 mRNA levels were up-regulated in a testosterone dose-dependent manner. The maximal effect was obtained with 583 nM (170 ng/ml) testosterone (P < 0.001). Treatment with 875 nM (250 ng/ml) showed that the regulation of claudin-11 by testosterone was time dependent (Fig. 3B), with an increase in claudin-11 mRNA levels after 48 h of testosterone treatment and a maximal effect after 72 h (P < 0.0001). In control experiments we ensured that basal claudin-11 mRNA levels were not affected throughout the culture period (from 4–96 h, Fig. 3B). Similar results were obtained at the protein level (Fig. 3C); claudin-11 protein levels were increased by more than 2-fold after 72 h of treatment with 875 nM (250 ng/ml) testosterone (P < 0.001).
|
Figure 4A shows an increase in testicular GATA-6 mRNA expression on d 26 (1.3-fold; P < 0.0001) and d 45 (1.5-fold; P < 0.0001) after irradiation. This increase in GATA-6 expression was observed in the testes depleted in the two most represented germ cell types (pachytene spermatocytes and spermatids). This would suggest that the increase in GATA-6 expression is probably related to the subsequent relative concentration of Sertoli cells. For this reason, we expressed claudin-11 mRNA levels as claudin-11/GATA-6 ratios in Fig. 4B. This figure shows that claudin-11/GATA-6 mRNA levels were similar to control levels in testes that were practically devoid of premeiotic germ cells (10 and 26 d after local irradiation), whereas claudin-11/GATA-6 mRNA levels were increased by 2.5-fold (P < 0.0001) in testes lacking postmeiotic germ cells (45 d after irradiation). For claudin-11 protein levels, Fig. 4C shows that a 2-fold increase (P = 0.0031) was found in the testes from rats killed 45 d after irradiation, compared with the sham-irradiated testes. Furthermore, in the second model of Sertoli cell-germ cell cocultures, a significant decrease (40%; P < 0.007) in claudin-11 mRNA levels was observed when Sertoli cells were cocultured with spermatids. In contrast, no changes in claudin-11 levels were evident in Sertoli cell-spermatocyte cocultures (Fig. 4D). Taken together, these data clearly suggest that postmeiotic germ cells exert an inhibitory effect on claudin-11 expression in Sertoli cells.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In the present study we primarily investigated whether gestational exposure to flutamide affected claudin-11 mRNA and protein levels in rat Sertoli cells at the time of two key events in postnatal testis development: 1) before puberty (postnatal d 14), during establishment of the hemotesticular barrier, which starts on postnatal d 15–18 in the rat (31); and 2) in adulthood (postnatal d 90), at the time of full spermatogenesis when all germ cell subtypes are present. To study gene expression changes in this model, the doses of the antiandrogen were chosen to avoid or minimize important germ cell loss that may confound interpretation of the effect of flutamide on testicular gene expression (7). Indeed, alterations in testicular cellularity (i.e. the ratio of somatic cells to germ cells) may confound interpretation of the effects of the antiandrogen on gene expression in the various testicular cell types (for review, see Ref.32), specifically here on claudin-11 expression in the Sertoli cell population.
To ensure that the variations in claudin-11 levels were specific and linked to exposure to the antiandrogen, we studied the expression of another gene specifically expressed in Sertoli cells, the GATA-6 gene that codes for a member of the GATA-binding protein family and has been reported not to be hormonally regulated in the testis (27). Our results show that GATA-6 expression was not altered in 0.4, 2, and 10-mg/kg·d flutamide-treated testes in either prepubertal (14 d old) or adult (90 d old) animals, confirming the absence of hormonal dependence of this gene.
The data reported here show that claudin-11 mRNA levels in prepubertal (14 d old) and adult (90 d old) rat testes showed regulation similarities, because neither were affected by exposure to 0.4 mg/kg·d flutamide, but both declined with a dose of 2 mg/kg·d of the antiandrogen. However, at the dose of 10 mg/kg·d, a major difference in claudin-11 mRNA modulation was found depending on the age of the testis. Indeed, the inhibition of claudin-11 expression observed at the dose of 10 mg/kg·d in prepubertal testis was no longer evident in adult testis. We hypothesized that the effect of flutamide at 10 mg/kg·d in adult rat testes could be due either to a U-curve response to the antiandrogen, with an absence of response to flutamide at the dose of 10 mg/kg·d, or to an additive event occurring in the adult testis (the presence of postmeiotic germ cells) that could enhance claudin-11 levels and thus mask the inhibitory effect of the antiandrogen on testicular claudin-11 expression that was detected in prepubertal testes exposed to 10 mg/kg·d flutamide. Based on these observations, it was therefore hypothesized that testicular claudin-11 expression could be under two (opposite) regulations: 1) a positive regulation exerted by androgens, which could explain the inhibitory effect of flutamide specifically observed at 2 mg/kg·d; and 2) an additive negative effect exerted by the meiotic and/or postmeiotic germ cells present in adult, but not prepubertal, testis.
Using a model of cultured Sertoli cells, it was shown that, as in the mouse (21), claudin-11 expression is positively regulated by androgens in the rat testis, because claudin-11 mRNA and protein levels were up-regulated in a time- and dose-dependant manner in cultured rat Sertoli cells treated with various doses of testosterone at different times. The maximal stimulatory effect on mRNA levels was obtained with 583 nM (170 ng/ml) testosterone after 72 h of treatment. Although high, this concentration of testosterone is within the range of those reported for interstitial fluid collected from adult untreated rats (31, 33). It remains to be determined, however, whether testosterone affects claudin-11 gene transcriptional activity, mRNA stability, or both or claudin-11 protein stability and/or turnover and whether the stimulatory effect on claudin-11 is direct, because there is a relatively long period of latency between the time of treatment and the stimulatory effect observed on claudin-11 expression. This period of latency could also be due to participation of peritubular myoid cells in the androgen-dependent control of claudin-11 expression, because the Sertoli cell cultures used contained peritubular myoid cells.
In this study we also report that claudin-11 expression could be negatively regulated by factors produced by postmeiotic germs cells. Indeed, using a model of locally irradiated (9 Gy) rat testis that allows sequential removal of the different populations of germ cells, we found an increase in claudin-11 expression at both mRNA and protein levels in testes that are devoid of postmeiotic germ cells, but not in testes lacking spermatogonia or spermatocytes. These results were also supported by the use of an in vitro model of Sertoli cells cocultured with germ cells (spermatocytes or spermatids), in which claudin-11 mRNA levels were inhibited exclusively in the presence of spermatids. These observations clearly support an inhibitory effect exerted by postmeiotic germ cells on claudin-11 expression in Sertoli cells. The factors mediating the inhibitory effect of germ cells on claudin-11 expression are not known at present, but good candidates could be cytokines such as TNF and TGFß3. Indeed, these factors are produced by germ cells (34, 35, 36) and have receptors localized on Sertoli cells (35, 37, 38), and previous results published by our laboratory (20) and by Lui et al. (39, 40, 41) have shown that they are potent inhibitors of claudin-11 expression.
This dual and opposed regulation by androgens and postmeiotic germ cells of the expression of claudin-11 could therefore explain the apparent lack of effect of fetal treatment with the antiandrogen in testes from adult rats treated with 10 mg/kg·d, at which dose maximal (postmeiotic) germ cell death was observed (Table 3) (12, 13). Indeed, at this dose, both regulatory events could coexist, with a flutamide-induced down-regulation of claudin-11 expression that could be opposed to the loss of postmeiotic germ cells up-regulating claudin-11 expression.
|
(20) and TGFß3 (39, 40, 41), which (negatively) control claudin-11 in Sertoli cells. Together, fetal androgen disruption appears to alter, in a complex manner, claudin-11 expression in postnatal rat testis. Indeed, although in the prepubertal testis, i.e. at the crucial moment of establishment of the hemotesticular barrier, a clear inhibitory effect is observed, in the adult testis, the apoptotic process that affects postmeiotic germ cells is likely to increase claudin-11 expression, as supported by the locally irradiated testis and coculture models we used here. These findings suggest that in utero exposure to flutamide may induce hypospermatogenesis through alterations of claudin-11 expression, potentially resulting in hemotesticular barrier (re)modeling impairment, although additional experiments are required to confirm this.
Finally, because claudin-11 is also expressed in the brain, we show in this study that claudin-11 expression is altered in the testis, but not in the brain, of male rats treated in utero with the antiandrogen flutamide, suggesting that transcription factors and coregulator elements in testis and brain might be different, thus leading to tissue specificity.
In summary, the present study shows the variations in the expression of claudin-11 in testes of prepubertal and adult rats exposed during gestation to the antiandrogen flutamide. Our results indicate that claudin-11 expression is altered in postnatal testes with fetal androgen disruption, and that in Sertoli cells, this gene and its product are under dual and opposite regulation, i.e. a stimulatory action exerted by androgens and an inhibitory effect originating from postmeiotic germ cells.
|
Footnotes |
|---|
First Published Online December 9, 2004
Abbreviations: AR, Androgen receptor; dNTP, deoxy-NTP; FSH-R, FSH receptor; GD, day of gestation; HPRT, hypoxanthine phosphoribosyltransferase; OSP, oligodendrocyte-specific protein; TBS-T, Tris-buffered saline containing 0.05% Tween; TUNEL, terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate nick end labeling.
Received July 1, 2004.
Accepted for publication December 3, 2004.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology 131:1149–1156 in mouse spermatogenic cells. Endocrinology 133:389–396 receptor p55 is under hormonal (follicle-stimulating hormone) control in testicular Sertoli cells. Biochem Biophys Res Commun 224:631–637[CrossRef][Medline]
This article has been cited by other articles:
 |
|
 |
|
  C. M.K. Morrow, G. Tyagi, L. Simon, K. Carnes, K. M. Murphy, P. S. Cooke, M.-C. C. Hofmann, and R. A. Hess Claudin 5 Expression in Mouse Seminiferous Epithelium Is Dependent upon the Transcription Factor Ets Variant 5 and Contributes to Blood-Testis Barrier Function Biol Reprod, November 1, 2009; 81(5): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Nicholls, C. A. Harrison, R. B. Gilchrist, P. G. Farnworth, and P. G. Stanton Growth Differentiation Factor 9 Is a Germ Cell Regulator of Sertoli Cell Function Endocrinology, May 1, 2009; 150(5): 2481 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chen, H. Cai, J.-L. Yang, C.-L. Lu, T. Liu, W. Yang, J. Guo, X.-Q. Hu, C.-H. Fan, Z.-Y. Hu, et al. Effect of Heat Stress on Expression of Junction-Associated Molecules and Upstream Factors Androgen Receptor and Wilms' Tumor 1 in Monkey Sertoli Cells Endocrinology, October 1, 2008; 149(10): 4871 - 4882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A Tarulli, S. J Meachem, S. Schlatt, and P. G Stanton Regulation of testicular tight junctions by gonadotrophins in the adult Djungarian hamster in vivo Reproduction, June 1, 2008; 135(6): 867 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. N. Yan, D. D. Mruk, W. M. Lee, and C. Y. Cheng Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in Sertoli cells FASEB J, June 1, 2008; 22(6): 1945 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Benbrahim-Tallaa, B. Siddeek, A. Bozec, V. Tronchon, A. Florin, C. Friry, E. Tabone, C. Mauduit, and M. Benahmed Alterations of Sertoli cell activity in the long-term testicular germ cell death process induced by fetal androgen disruption J. Endocrinol., January 1, 2008; 196(1): 21 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Le Magueresse-Battistoni Serine proteases and serine protease inhibitors in testicular physiology: the plasminogen activation system Reproduction, December 1, 2007; 134(6): 721 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J Kaitu'u-Lino, P. Sluka, C. F H Foo, and P. G Stanton Claudin-11 expression and localisation is regulated by androgens in rat Sertoli cells in vitro Reproduction, June 1, 2007; 133(6): 1169 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-S. Wang, S. Yeh, L.-M. Chen, H.-Y. Lin, C. Zhang, J. Ni, C.-C. Wu, P. A. di Sant'Agnese, K. L. deMesy-Bentley, C.-R. Tzeng, et al. Androgen Receptor in Sertoli Cell Is Essential for Germ Cell Nursery and Junctional Complex Formation in Mouse Testes Endocrinology, December 1, 2006; 147(12): 5624 - 5633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Sluka, L O'Donnell, J R Bartles, and P G Stanton FSH regulates the formation of adherens junctions and ectoplasmic specialisations between rat Sertoli cells in vitro and in vivo. J. Endocrinol., May 1, 2006; 189(2): 381 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maire, A. Florin, K. Kaszas, D. Regnier, P. Contard, E. Tabone, C. Mauduit, R. Bars, and M. Benahmed Alteration of Transforming Growth Factor-{beta} Signaling System Expression in Adult Rat Germ Cells with a Chronic Apoptotic Cell Death Process after Fetal Androgen Disruption Endocrinology, December 1, 2005; 146(12): 5135 - 5143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. El Chami, F. Ikhlef, K. Kaszas, S. Yakoub, E. Tabone, B. Siddeek, S. Cunha, C. Beaudoin, L. Morel, M. Benahmed, et al. Androgen-dependent apoptosis in male germ cells is regulated through the proto-oncoprotein Cbl J. Cell Biol., November 21, 2005; 171(4): 651 - 661. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
) or with (
) 875 nM (250 ng/ml) testosterone for different treatment times (4–96 h; B) before determining claudin-11 mRNA levels. Sertoli cells were cultured in the absence (0) or the presence of 875 nM testosterone for 72 h before evaluating claudin-11 protein levels (C). The data show representative autoradiograms (upper panel) and histograms (lower panel) and are expressed as the mean ± SEM from at least three different experiments. Results are represented as a percentage of the ratio of claudin-11/ß-actin mRNA detected in the controls (untreated cells).